5 -12 (62) 2023 — Mirzoyeva M.R., Bakhshilloyeva R.E. — IMPORTANCE OF IMMUNOLOGICAL CHANGES IN VITILIGO DISEASE

IMPORTANCE OF IMMUNOLOGICAL CHANGES IN VITILIGO DISEASE

Mirzoyeva M.R., Bukhara State Medical Institute named after Abu Ali ibn Sina

Bakhshilloyeva R.E. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This article covers the results of today’s advances in science about the role of immunological processes, which are important in vitiligo. Investigations conducted on the identification of cellular and tissue hormones – cytokines, which participate as promoters of melanocyte apoptosis or suppressing its activity in the tissue, are studied. The collected data serve as the main source of information important in the study of the etiopathogenesis of the disease.

Key words: vitiligo, apoptosis, immunopathogenesis, cytokine, oxidative stress

First page

23

Last page

27

For citation: Mirzoyeva M.R., Bakhshilloyeva R.E. – IMPORTANCE OF IMMUNOLOGICAL CHANGES IN VITILIGO DISEASE //New Day in Medicine 2023 12(62): https://newdaymedicine.com/index.php/2023/12/10/l-559/

LIST OF REFERENCES:

  1. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. // Lancet 2015;386:74-84.  DOI 10.1016/S0140-6736(14)60763-7
  2. Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol 2020;38:621-48. DOI 10.1146/annurev-immunol-100919-023531
  3. Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al.. Vitiligo. Nat Rev Dis Primers 2015;1:15011.   10.1038/nrdp.2015.11
  4. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. // Clin Rev Allergy Immunol 2018;54:52-67.  DOI 10.1007/s12016-017-8622-7
  5. Van Geel N, Mollet I, Brochez L, Dutré M, De Schepper S, Verhaeghe E, et al.. New Insights in Segmental Vitiligo: Case Report and Review of Theories. // Br J Dermatol 2012;166:240–6. DOI 10.1111/j.1365-2133.2011.10650.x
  6. Boniface K, Seneschal J. Vitiligo as a Skin Memory Disease: The Need for Early Intervention With Immunomodulating Agents and a Maintenance Therapy to Target Resident Memory T Cells. // Exp Dermatol 2019;28:656–61.  DOI 10.1111/exd.13879
  7. Riding RL, Harris JE. The Role of Memory Cd8+ T Cells in Vitiligo. // J Immunol 20194203:11-9. DOI 10.4049/jimmunol.1900027 
  8. Seneschal J, Boniface K, D’Arino A, Picardo M. An Update on Vitiligo Pathogenesis. // Pigment Cell Melanoma Res 2021;34:236-43. DOI 10.1111/pcmr.12949
  9. Dwivedi M, Kemp EH, Laddha NC, Mansuri MS, Weetman AP, Begum R. Regulatory T Cells in Vitiligo: Implications for Pathogenesis and Therapeutics. // Autoimmun Rev 2015;14:49-56.
  10. Mukhatayev Z, Ostapchuk YO, Fang D, Le Poole IC. Engineered Antigen-Specific Regulatory T Cells for Autoimmune Skin Conditions. // Autoimmun Rev 2021;20:102-761.   
  11. Rosmarin D, Pandya AG, Lebwohl M, Grimes P, Hamzavi I, Gottlieb AB, et al. Ruxolitinib Cream for Treatment of Vitiligo: A Randomised, Controlled, Phase 2 Trial. // Lancet 2020; 396:110-20.  
  12. Passeron T. First Step in a New Era for Treatment of Patients With Vitiligo. // Lancet 2020;396:74-5.  DOI 10.1016/S0140-6736(20)30747-9 
  13. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical
    Aspects, Immunopathogenesis, and Therapy. // Clin Rev Allergy Immunol
    2018;54:52-67. doi:10.1007/s12016-017-8622-7
  14. Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al. Vitiligo. Nat Rev Dis Primers 2015;1:15011. doi: 10.1038/nrdp.2015.11
  15. Willemsen M, LinkutėR, Luiten RM, Matos TR. Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma. Pigment Cell Melanoma Res 2019;32:612–22. doi: 10.1111/pcmr.12803
  16. Riding RL, Harris JE. The Role of Memory CD8+ T Cells in Vitiligo.
    // J Immunol 2019;203:11–9. doi: 10.4049/jimmunol.1900027
  17. Roberts GHL, Santorico SA, Spritz RA. The genetic architecture of vitiligo.
    Pigment Cell Melanoma Res 2020;33:8–15. doi: 10.1111/pcmr.12848
  18. Jin Y, Santorico SA, Spritz RA. Pediatric to Adult Shift in Vitiligo Onset
    Suggests Altered Environmental Triggering. // J Invest Dermatol 2020;140:241–243.e4. doi: 10.1016/j.jid.2019.06.131
  19. Spritz RA, Santorico SA. The Genetic Basis of Vitiligo. // J Invest Dermatol
    2020;41(2):265–73. doi: 10.1016/j.jid.2020.06.004
  20. Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, et al.
    Genetic susceptibility to vitiligo: reсent progress from genome-wide association studies // Dermatologica Sinica. 2014;32;225–232.

file

download